Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 21.00M
March 31, 2026 20.98M
December 31, 2025 20.81M
September 30, 2025 20.80M
June 30, 2025 20.77M
March 31, 2025 20.72M
December 31, 2024 411.58M
September 30, 2024 411.26M
June 30, 2024 411.11M
March 31, 2024 410.74M
December 31, 2023 408.82M
September 30, 2023 408.55M
June 30, 2023 408.13M
March 31, 2023 407.27M
December 31, 2022 404.35M
September 30, 2022 403.83M
June 30, 2022 397.35M
March 31, 2022 396.94M
December 31, 2021 396.60M
September 30, 2021 395.61M
June 30, 2021 395.22M
March 31, 2021 394.76M
December 31, 2020 392.54M
September 30, 2020 388.83M
June 30, 2020 385.85M
Date Value
March 31, 2020 361.71M
December 31, 2019 360.10M
September 30, 2019 357.53M
June 30, 2019 331.31M
March 31, 2019 330.58M
December 31, 2018 325.85M
September 30, 2018 304.09M
June 30, 2018 293.94M
March 31, 2018 293.58M
December 31, 2017 271.02M
September 30, 2017 270.88M
June 30, 2017 270.79M
March 31, 2017 270.70M
December 31, 2016 269.36M
September 30, 2016 269.18M
June 30, 2016 184.55M
March 31, 2016 184.44M
December 31, 2015 183.40M
September 30, 2015 183.33M
June 30, 2015 183.26M
March 31, 2015 177.10M
December 31, 2014 174.59M
September 30, 2014 174.59M
June 30, 2014 172.89M
March 31, 2014 172.89M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 101.60M
DBV Technologies SA 59.18M
Alkermes Plc 167.54M
Akari Therapeutics Plc 1.750M
Liquidia Corp. 89.10M